Skip to content
Screener

Alumis Inc. ALMS Other Income (Expense)

Other Income (Expense) at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$61M+112%
Amgen logo
AmgenAMGN
-$73M+81.5%
Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
$4.61M+12.9%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
-$4.82M-237%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
-$468K-127%
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
-$98K+45.9%

Segments

By segment

See full
Single Reportable$5.36M+109%

Other financials

Income statement

See full
Revenue$1.7M-90.0%
Operating income-$98.4M+3.1%
Net income-$93.1M+6.0%
EPS (diluted)-$0.74+59.3%

Balance sheet

See full
Cash & equivalents$63.9M-50.3%
Total debt$35.7M+1,881%
Total equity$567.0M+237%
Total assets$671.6M+157%

Cash flow

See full
Operating cash flow-$87.1M-8.4%
CapEx$164.0K+343%
Free cash flow-$87.2M-8.5%

Valuation

See full
Market cap$3.54B+686%
Enterprise value$3.52B+940%
P/S421.8×

Profitability

See full
Operating margin-5,364%
Net margin-2,825.7%
FCF margin-4,487.4%

Returns & leverage

See full
Return on equity-64.6%
Debt / equity0.1×+0.1×
Current ratio7.5×+3.8×

Where this comes from

Reported directly by Alumis Inc. in its filing.

Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.

The source filing: Alumis Inc.’s 10-Q, filed May 14, 2026.

Filed
May 14, 2026, 4:16 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001847367-26-000010
(in thousands, except share and per share amounts)Three Months Ended March 31, 2026Three Months Ended March 31, 2025
Other income (expense):
Interest income5,3492,609
Other income (expenses), net7(44)
Total other income (expense), net5,3562,565
Net loss$(93,053)$(98,963)
Other comprehensive income (loss):
Unrealized gain (loss) on marketable securities, net(655)(48)
Total comprehensive loss$(93,708)$(99,011)

Item 1. Financial Statements (Unaudited)

FAQ

What is Alumis Inc.'s other income (expense)?
Alumis Inc. (ALMS) reported other income (expense) of $5.36M in Q1 2026.
How has Alumis Inc.'s other income (expense) changed year-over-year?
Alumis Inc.'s other income (expense) increased by 108.8% year-over-year, from $2.57M to $5.36M.
What is the long-term trend for Alumis Inc.'s other income (expense)?
Over 2 years (2023 to 2025), Alumis Inc.'s other income (expense) has grown at a 696.7% compound annual growth rate (CAGR), from $3.18M to $201.92M.
What does other income (expense) mean?
Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.

Ask your AI about Alumis Inc.'s other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude